OCRL Antikörper (AA 121-271) (FITC)
Kurzübersicht für OCRL Antikörper (AA 121-271) (FITC) (ABIN7156318)
Target
Alle OCRL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 121-271
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Inositol polyphosphate 5-phosphatase OCRL-1 protein (121-271AA)
-
Isotyp
- IgG
-
-
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-239) antibody
OCRL Reaktivität: Human WB, ELISA, IHC (p), RNAi Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 121-271) antibodyOCRL Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (Internal Region) antibodyOCRL Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
-
Andere Bezeichnung
- OCRL
-
Hintergrund
-
Background: Converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Also converts inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate and inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4-trisphosphate (PubMed:25869668, PubMed:7761412, PubMed:9430698). May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes. Involved in primary cilia assembly (PubMed:22228094, PubMed:22543976).
Aliases: EC 3.1.3.36 antibody, Inositol polyphosphate 5 phosphatase OCRL 1 antibody, Inositol polyphosphate 5 phosphatase OCRL1 antibody, Inositol polyphosphate 5-phosphatase OCRL-1 antibody, INPP5F antibody, LOCR antibody, Lowe oculocerebrorenal syndrome protein antibody, NPHL2 antibody, OCRL 1 antibody, OCRL antibody, OCRL_HUMAN antibody, OCRL1 antibody, Oculocerebrorenal syndrome of Lowe antibody, Phosphatidylinositol polyphosphate 5 phosphatase antibody
-
UniProt
- Q01968
-
Pathways
- Inositol Metabolic Process
Target
-
